Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
JAZZ Analyst Ratings
Strong Buy
17 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
JAZZ Stock 12 Month Forecast
Average Price Target
$193.82
▲(53.34% Upside)
| Highest Price Target$230.00 | Average Price Target$193.82 | Lowest Price Target$150.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
Reiterated
03/19/25
Jefferies
Reiterated
03/14/25
H.C. Wainwright
Reiterated
03/10/25
TD Cowen
Reiterated
03/07/25
Truist Financial
Reiterated
03/06/25
Morgan Stanley
Initiated
03/06/25
Stifel Nicolaus
Reiterated
03/05/25
Leerink Partners
Reiterated
03/05/25
Needham
Reiterated
03/05/25
Cantor Fitzgerald
$140→$150
Hold
18.67%
Upside
Downgraded
02/26/25
Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor FitzgeraldJazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
Robert W. Baird
$162→$167
Buy
32.12%
Upside
Reiterated
02/26/25
Jazz Pharmaceuticals price target raised to $167 from $162 at BairdJazz Pharmaceuticals price target raised to $167 from $162 at Baird
J.P. Morgan
$200→$209
Buy
65.35%
Upside
Reiterated
02/26/25
Jazz Pharmaceuticals (JAZZ) PT Raised to $209 at JPMorganJPMorgan analyst Jessica Fye raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $209.00 (from $200.00) while maintaining a Overweight rating.
Wells Fargo
$170
Buy
34.49%
Upside
Reiterated
02/26/25
Wells Fargo Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)
Piper Sandler
$163→$176
Buy
39.24%
Upside
Reiterated
02/26/25
Piper Sandler Sticks to Its Buy Rating for Jazz Pharmaceuticals (JAZZ)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
Reiterated
03/19/25
Jefferies
Reiterated
03/14/25
H.C. Wainwright
Reiterated
03/10/25
TD Cowen
Reiterated
03/07/25
Truist Financial
Reiterated
03/06/25
Morgan Stanley
Initiated
03/06/25
Stifel Nicolaus
Reiterated
03/05/25
Leerink Partners
Reiterated
03/05/25
Needham
Reiterated
03/05/25
Cantor Fitzgerald
$140→$150
Hold
18.67%
Upside
Downgraded
02/26/25
Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor FitzgeraldJazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
Robert W. Baird
$162→$167
Buy
32.12%
Upside
Reiterated
02/26/25
Jazz Pharmaceuticals price target raised to $167 from $162 at BairdJazz Pharmaceuticals price target raised to $167 from $162 at Baird
J.P. Morgan
$200→$209
Buy
65.35%
Upside
Reiterated
02/26/25
Jazz Pharmaceuticals (JAZZ) PT Raised to $209 at JPMorganJPMorgan analyst Jessica Fye raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $209.00 (from $200.00) while maintaining a Overweight rating.
Wells Fargo
$170
Buy
34.49%
Upside
Reiterated
02/26/25
Wells Fargo Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)
Piper Sandler
$163→$176
Buy
39.24%
Upside
Reiterated
02/26/25
Piper Sandler Sticks to Its Buy Rating for Jazz Pharmaceuticals (JAZZ)
JAZZ Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
17
18
15
5
6
Buy
12
16
14
23
24
Hold
5
4
3
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
34
38
32
29
31
Each month's total comprises the sum of three months' worth of ratings.
JAZZ Financial Forecast
JAZZ Stock Forecast FAQ
What is JAZZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Jazz Pharmaceuticals’s 12-month average price target is $193.82.
What is JAZZ’s upside potential, based on the analysts’ average price target?
Jazz Pharmaceuticals has 53.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is JAZZ a Buy, Sell or Hold?
Jazz Pharmaceuticals has a consensus rating of Strong Buy which is based on 17 buy ratings, 1 hold ratings and 0 sell ratings.
What is Jazz Pharmaceuticals’s price target?
The average price target for Jazz Pharmaceuticals is $193.82. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $230.00 ,the lowest forecast is $150.00. The average price target represents 53.34% Increase from the current price of $126.4.
The highest analyst price target is $230.00 ,the lowest forecast is $150.00. The average price target represents 53.34% Increase from the current price of $126.4.
What do analysts say about Jazz Pharmaceuticals?
Jazz Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of JAZZ?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.